£23 million funding for cutting edge health projects
£23 million of government funding has been awarded to cutting edge health projects.
Read More
Tag: Biomedical Catalyst
Discuva gets £1.5m to support antibiotics development
Cambridge, UK-based drug discovery group Discuva has been awarded £1.5 million of Biomedical Catalyst* money to support development of novel antibiotics to tackle the issue of multidrug-resistance and life-threatening bacterial infections.
Read More
Cypralis awarded grant to advance acute pancreatitis drug
UK life sciences firm Cypralis has been awarded new funding by Innovate UK to take forward its work on cyclophilin D inhibitors targeting degenerative diseases.
Read More
Gov’t streams £220m into commercialising innovations
The government has announced that life sciences and university sectors will receive a “package of support” including a cash stream of £220 million to help translate technology breakthroughs into commercial successes.
Read More
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
- Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer
- ErVimmune raises 17m euros in funding to develop cancer vaccine
